Yesterday | PR-inside.com
Allergan, Inc. a " Product Pipeline Review a " H2 2011 -...
A A A' Product Pipeline Review A A A' H2 2011 - a new company profile report on companiesandmarkets.com Allergan, Inc.
Cosmetic treatment for men: Beauty and the beasts
IN GEORGES ROMAN'S clinic in London, women queue to see a cosmetic dermatologist renowned for zapping wrinkles and smoothing brows.
Equity Analysis: Amazon.com's Kindle Catalyst, Micron Tech, Zynga, Allergan
Amazon.com Inc. : Pacific Crest increased its 2012 estimate for unit sales of Amazon's Kindle Fire to 14.9M from 12.7M. The firm believes that increased adoption of Kindle Fire tablets should drive share gains for Amazon over the longer term, but it maintains a Sector Perform rating on the stock.
Allergan (AGN) Share Price Target Raised to $98.00 by Morgan Stanley (MS) Analysts
Research analysts at Morgan Stanley increased their price target on shares of Allergan from $90.00 to $98.00 in a report issued on Wednesday.
2 LA clinics temporarily halt Lap-Band surgeries
Two Los Angeles-area outpatient clinics affiliated with the 1-800 GET-THIN marketing company have temporarily stopped Lap-Band weight-loss surgeries while they conduct a review of the procedure.
Allergan Reports Rise in Fourth Quarter 2011 Sales
IRVINE, Calif. - Allergan, Inc. reported $1,382.8 million total product net sales for the fourth quarter ended Dec.
Allergan Reports Inline Results And Gives Mixed Guidance
Allergan reported Q4 EPS of $1.00, inline with estimates. Revenues came in at $1.4 billion, which was also inline with estimates as well.Allergan said it sees 2012 EPS of $4.13 - $4.19, vs.
Zacks Investment Research Analysts Reiterate a "Neutral" Rating on Allergan
Allergan 's stock had its "neutral" rating reaffirmed by Zacks Investment Research in a report issued on Friday.
Lap-Band Maker, Allergen, Halts Sales To 1-800-GET-THIN Clinics
Five Southland patients have died since 2009 after undergoing Lap-Band surgeries in 1-800-GET-THIN clinics in Beverly Hills and West Hills, according to the Times .
Allergan to rely less on U.S. for sales, Asia key
Allergan Inc, maker of wrinkle treatment Botox, eye drops and obesity treatments, said it will rely less on the United States for revenue in coming years as its products gain wider acceptance in Asia, particularly China.
Daily Dividend Report: UNP, V, LVS, AGN, PRGO
This morning, Union Pacific declared its quarterly dividend of 60 cents per share, maintaining the amount paid to shareholders last quarter.
Allergan Reports Fourth Quarter 2011 Operating Results
IRVINE, Calif.-- --Feb 2, 2012 - Allergan, Inc. today announced operating results for the quarter ended December 31, 2011.
Allergan Management Discusses Q4 2011 Results - Earnings Call Transcript
Hello, and welcome to the Allergan Fourth Quarter 2011 Earnings Call. [Operator Instructions] At the request of the company, today's conference is being recorded.
Wall Street Analyst Alerts: Dow Chemical, Micron Tech, Allergan, Core Labs
Micron Technology Inc. : Pacific Crest views planned capex reductions at both Elpida and Hynix as a positive for Micron and the DRAM industry.
Allergan halts Lap-Band sales to surgery chain
Allergan will no longer sell its Lap-Band to theA surgical centersA affiliated with theA controversial 1-800-Get-Thin marketing campaign.
Allergan 4th-quarter profit, eye drug sales rise
The company's forecast for 2012 was lower than anticipated, sending its shares down as much as 2.8 percent, although some analysts consider the outlook conservative.
Allergan Inc. Earnings: Margins Expand Again, Profit Rises
S&P 500 component Allergan Inc. reported its results for the fourth quarter. Allergan is a global specialty health care company.
Allergan and Cigna Keep Shareholders Anxious Ahead of Earnings
Allergan, Inc. will unveil its latest earnings on Thursday, February 2, 2012. The average estimate of analysts is for profit of $1 per share, a rise of 13.6% from the company's actual earnings for the same quarter a year ago.
Earnings Preview: Allergan - Analyst Blog
Allergan, Inc. is scheduled to announce its fourth quarter and full year 2011 results on February 2, 2012, before the opening bell.
Forbes Earnings Preview: Allergan
Optimism surrounds Allergan , as it gets ready to report its fourth quarter results on Thursday, February 2, 2012.